| [1] |
Chinese Society of Pacing and Electrophysiology, Chinese Society of Arrhythmias, Atrial Fibrillation Center Union of China. Current knowledge and management of atrial fibrillation: consensus of Chinese experts 2021. Chin. J. Cardiac. Arrhyth. 2022, 26, 15–88.
|
| [2] |
Hindricks, G.; Potpara, T.; Dagres, N.; Arbelo, E.; Bax, J.J.; Blomström-Lundqvist, C.; Boriani, G.; Castella, M.; Dan, G.A.; Dilaveris, P.E.; Fauchier, L.; Filippatos, G.; Kalman, J.M.; La Meir, M.; Lane, D.A.; Lebeau, J.P.; Lettino, M.; Lip, G.Y.H.; Pinto, F.J.; Thomas, G.N.; Valgimigli, M.; Van Gelder, I.C.; Van Putte, B.P.; Watkins, C.L.; ESC Scientific Document Group. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur. Heart J. 2021, 42, 373–498.
|
| [3] |
Douketis, J.D.; Spyropoulos, A.C.; Murad, M.H.; Arcelus, J.I.; Dager, W.E.; Dunn, A.S.; Fargo, R.A.; Levy, J.H.; Samama, C.M.; Shah, S.H.; Sherwood, M.W.; Tafur, A.J.; Tang, L.V.; Moores, L.K. Perioperative management of antithrombotic therapy an American College of Chest Physicians clinical practice guideline. Chest. 2022, 162, e207–e243.
|
| [4] |
Douketis, J.D.; Spyropoulos, A.C.; Spencer, F.A.; Mayr, M.; Jaffer, A.K.; Eckman, M.H.; Dunn, A.S.; Kunz, R. Perioperative management of antithrombotic therapy antithrombotic therapy and prevention of thrombosis, 9th Ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012, 141, e326S–e350S.
|
| [5] |
Douketis, J.; Berger, P.; Dunn, A.; Jaffer, A.; Spyropoulos, A.; Becker, R.; Ansell, J. The perioperative management of antithrombotic therapy: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008, 06, 299S-339S.
|
| [6] |
Chinese Medical Association Electrophysiology and Pacing Branch, Chinese Medical Association Arrhythmia professional committee. Consensus of Chinese experts on surgical practice of general pacemaker and implantable cardioverter defibrillator (2023). Arrhythmia. 2023, 27, 188–224.
|
| [7] |
Birnie, D.H.; Healey, J.S.; Wells, G.A.; Ayala-Paredes, F.; Coutu, B.; Sumner, G.L.; Becker, G.; Verma, A.; Philippon, F.; Kalfon, E.; Eikelboom, J.; Sandhu, R.K.; Nery, P.B.; Lellouche, N.; Connolly, S.J.; Sapp, J.; Essebag, V. Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2). Eur. Heart J. 2018, 39, 3973–3979.
|
| [8] |
Non-cardiac Anesthesia Branch of Chinese Society of Cardiothoracic and Vascular Anesthesia, Branch of Cardiovascular Physicians of Chinese Medical Doctor Association, China Cardiovascular Health Alliance. Antithrombotic drugs perioperative management of multidisciplinary experts consensus. J. Chin. Med. J. 2020, 100, 3058–3074.
|
| [9] |
Chan, Y.H.; Chan, C.Y.; Chen, S.W.; Chao, T.F.; Lip, G.Y.H. Comparisons of effectiveness and safety between on-label dosing, off-label underdosing, and off-label overdosing in Asian and non-Asian atrial fibrillation patients treated with rivaroxaban: a systematic review and meta-analysis of observational studies. Europace. 2023, 25, euad288.
|
| [10] |
Patel, M.R.; Mahaffey, K.W.; Garg, J.; Pan, G.H.; Singer, D.E.; Hacke, W.; Breithardt, G.; Halperin, J.L.; Hankey, G.J.; Piccini, J.P.; Becker, R.C.; Nessel, C.C.; Paolini, J.F.; Berkowitz, S.D.; Fox, K.A.A.; Califf, R.M.; ROCKET AF Investigators. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N. Engl. J. Med. 2011, 365, 883–891.
|
| [11] |
Hori, M.; Matsumoto, M.; Tanahashi, N.; Momomura, S.; Uchiyama, S.; Goto, S.; Izumi, T.; Koretsune, Y.; Kajikawa, M.; Kato, M.; Ueda, H.; Iwamoto, K.; Tajiri, M. Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation–the J-ROCKET AF study. Circ. J. 2012, 76, 2104–2111.
|
| [12] |
Zheng, Y.L. Associate Group of anticoagulant pharmacists, Branch of Cardiovascular Pharmacy, Chinese Society of Cardiothoracic and Vascular Anesthesia. Pharmaceutical recommendations for rational use of direct oral anticoagulants and prescription quality evaluation. Chin. J. Circ. 2019, 39, 217–227.
|
)
>
>